Edsbäcker S[au] - Search Results

Year	Number of Results
1982	3
1983	1
1984	1
1985	1
1987	3
1993	3
1994	2
1996	1
1997	1
1998	3
1999	5
2000	1
2001	7
2002	3
2003	3
2004	2
2006	1
2007	1
2008	2
2009	2
2010	1
2013	1
2016	2
2017	4
2023	0

1

Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease.

Edsbäcker S, Andersson T. Edsbäcker S, et al. Clin Pharmacokinet. 2004;43(12):803-21. doi: 10.2165/00003088-200443120-00003. Clin Pharmacokinet. 2004. PMID: 15355126 Review.

2

Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids?

Edsbäcker S, Wollmer P, Selroos O, Borgström L, Olsson B, Ingelf J. Edsbäcker S, et al. Pulm Pharmacol Ther. 2008;21(2):247-58. doi: 10.1016/j.pupt.2007.08.005. Epub 2007 Sep 6. Pulm Pharmacol Ther. 2008. PMID: 17950641 Review.

3

Pharmacological factors that influence the choice of inhaled corticosteroids.

Edsbäcker S. Edsbäcker S. Drugs. 1999;58 Suppl 4:7-16; discussion 51-2. doi: 10.2165/00003495-199958004-00002. Drugs. 1999. PMID: 10711854 Review.

4

Airway selectivity: an update of pharmacokinetic factors affecting local and systemic disposition of inhaled steroids.

Edsbäcker S, Johansson CJ. Edsbäcker S, et al. Basic Clin Pharmacol Toxicol. 2006 Jun;98(6):523-36. doi: 10.1111/j.1742-7843.2006.pto_355.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16700813 Free article. Review.

5

Once-daily inhaled budesonide for the treatment of asthma: clinical evidence and pharmacokinetic explanation.

Selroos O, Edsbäcker S, Hultquist C. Selroos O, et al. Among authors: edsbacker s. J Asthma. 2004;41(8):771-90. doi: 10.1081/jas-200038344. J Asthma. 2004. PMID: 15641626 Review.

6

Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available data.

Edsbäcker S, Brattsand R. Edsbäcker S, et al. Ann Allergy Asthma Immunol. 2002 Jun;88(6):609-16. doi: 10.1016/S1081-1206(10)61893-5. Ann Allergy Asthma Immunol. 2002. PMID: 12086369 Review.

7

Rectal pharmacokinetics of budesonide.

Dahlstrom K, Edsbacker S, Kallen A. Dahlstrom K, et al. Among authors: edsbacker s. Eur J Clin Pharmacol. 1996;49(4):293-8. doi: 10.1007/BF00226330. Eur J Clin Pharmacol. 1996. PMID: 8857075 Clinical Trial.

8

Oral availability of fluticasone propionate.

Andersson P, Brattsand R, Dahlström K, Edsbäcker S. Andersson P, et al. Among authors: edsbacker s. Br J Clin Pharmacol. 1993 Aug;36(2):135-6. doi: 10.1111/j.1365-2125.1993.tb04211.x. Br J Clin Pharmacol. 1993. PMID: 8398584 Free PMC article. No abstract available.

9

Colds as predictors of the onset and severity of COPD exacerbations.

Johnston NW, Olsson M, Edsbäcker S, Gerhardsson de Verdier M, Gustafson P, McCrae C, Coyle PV, McIvor RA. Johnston NW, et al. Among authors: edsbacker s. Int J Chron Obstruct Pulmon Dis. 2017 Mar 10;12:839-848. doi: 10.2147/COPD.S127146. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28331305 Free PMC article.

10

Kinetics of the epimeric glucocorticoid budesonide.

Ryrfeldt A, Edsbäcker S, Pauwels R. Ryrfeldt A, et al. Among authors: edsbacker s. Clin Pharmacol Ther. 1984 Apr;35(4):525-30. doi: 10.1038/clpt.1984.71. Clin Pharmacol Ther. 1984. PMID: 6705451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results